HomeALVIO • EPA
add
Valerio Therapeutics SA
Previous close
€0.066
Year range
€0.040 - €0.14
Market cap
7.42M EUR
Avg Volume
28.85K
P/E ratio
-
Dividend yield
-
Primary exchange
EPA
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 44.50K | — |
Operating expense | 5.43M | -8.00% |
Net income | -5.48M | 5.89% |
Net profit margin | -12.31K | — |
Earnings per share | — | — |
EBITDA | -4.71M | 20.70% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.00M | -76.21% |
Total assets | 29.34M | -33.35% |
Total liabilities | 25.32M | 21.47% |
Total equity | 4.02M | — |
Shares outstanding | 153.97M | — |
Price to book | 2.20 | — |
Return on assets | -46.54% | — |
Return on capital | -79.19% | — |
Cash Flow
Net change in cash
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -5.48M | 5.89% |
Cash from operations | -3.42M | 25.08% |
Cash from investing | -18.00K | 62.89% |
Cash from financing | 2.09M | -63.40% |
Net change in cash | -1.42M | -226.68% |
Free cash flow | -2.50M | 31.00% |
About
Founded
1997
Website
Employees
38
